Smart Healthcare Market Key Companies Driving Innovation and Growth

FAQ's

Answer : According to Precedence Research, the global biomarkers market size was estimated at USD 63.06 billion in 2021 and is predicted to reach USD 207.46 billion by the end of 2030.

Answer : The global biomarkers market is growing at a CAGR of 14.1% from 2021 to 2030.

Answer : Biomarker (portmanteau of biological marker) is the attribute that is accurately measured and assessed as an indicator of regular biological processes, pathogenic procedures or pharmacological reaction to a therapeutic interference.

Answer : Factors such as high incidence of cancer, increasing focus on establishment of biomarker-based diagnostic methods, and growing number of contract research organizationsare driving the growth of biomarkers market.

Answer : In 2019, North America dominated the global market with a market share of more than 39%.

Answer : Safety Biomarkers segment recorded the prime market share in the global biomarkers market by type in 2019.

Answer : The use of biomarkers is on a constant rise in drug discovery and development majorly due to the advantages offered by biomarkers to scaleup the clinical development stage. These factors contribute to the growth of drug discovery & development segment.

Answer : The major companies functioning in the worldwide biomarkers market are Bio-Rad Laboratories, Inc., Epigenomics AG, Qiagen, Abbott, Johnson & Johnson Services, Inc., F. Hoffmann-La Roche Ltd., Agilent Technologies, Inc., Abbott, Siemens, and Thermo Fisher Scientific, Inc. among others.